|

Atrial Fibrillation in Beta-Thalassemia

RECRUITINGSponsored by University Hospital of Ferrara
Actively Recruiting
SponsorUniversity Hospital of Ferrara
Started2022-09-01
Est. completion2032-06-01
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT05508932

Summary

The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.

Eligibility

Age: 18 Years+
Inclusion Criteria:

1. Transfusion-dependent Beta-thalassemia;
2. Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;
3. Electrocardiogram performed;
4. Echocardiogram performed.

Exclusion Criteria:

1. Age \<18 years;
2. State Of pregnancy;
3. Inability to give informed consent.

Conditions3

Atrial FibrillationHeart DiseaseThalassemia

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.